Latest news - Novo Nordisk
WEB10 July 2024. Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec. Read more. News archive. Featured stories. PRODUCTION. Expanding our fill-finish capacity.
European Drug Agency Supports Novo Nordisk's Blockbuster …
WEB1 day ago · The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide 2.4 ...
Novo Nordisk Just Took a $530 Million Step Onto Moderna's …
WEB2 days ago · Novo Nordisk's deal with Korro is worth a total of $530 million in funding, milestone payments, royalties, and up-front payments to get the ball rolling. That makes the agreement a meaty but ...
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity …
WEB1 day ago · Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1) inverse ...
News Details - novonordisk.com
WEB2 days ago · Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to …
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy …
WEBApr 20, 2024 · Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
News details - Novo Nordisk
WEBNews details. 12:46 PM. June 4 2021. Novo Nordisk receives FDA approval for Wegovy™ to treat adults with obesity based on unprecedented efficacy for a prescription medicine in clinical trials.
Novo Nordisk to boost output of Wegovy, Ozempic with new NC …
WEBJun 24, 2024 · Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy ...
Novo Nordisk bets $600M biobucks on NanoVation's ability to …
WEB3 days ago · Novo Nordisk's latest RNA deal involves $530M biobucks to sing in Korro's opera. Novo is paying an upfront fee of undisclosed size to enter into the collaboration. Factoring in milestones, the ...
Novo Nordisk signs deals worth up to $1bn with US biotechs in …
WEBJan 4, 2024 · Novo Nordisk has signed deals worth up to $1bn with US biotech start-ups developing treatments for obesity and other cardiometabolic diseases, as the Wegovy manufacturer seeks to stay ahead in...
Skip to content